Unblinded Data Collection Study of Concussion Using BrainPulse
18 septembre 2018 mis à jour par: Jan Medical, Inc.
A Study to Assess the Effectiveness of the BrainPulse as an Aid to the Diagnosis of Concussion
This is a prospective, non-blinded, matched control study of young athletes (ages 10-28 years old) in collegiate sports.
The cohorts are defined in accordance to the athlete's exposure of injury.
All subjects will complete a minimum of one recording based on their assigned cohort.
Concussed athletes will complete an additional 3 weeks of follow-up recordings post injury.
The symptomatic evaluation, physical examination, neurological baseline testing, and BrainPulse recordings will be entered in a database to determine clinical outcome and assess device utilization.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Description détaillée
Cohort I is defined as all enrolled athletes at the University of Wyoming and is divided into two sub-cohorts: Cohort Ia include all athletes participating in Division 1 Athletics; Cohort Ib are athletes subscribed to the Head Health Network.
Cohort II is defined as all injured athletes participating in the teams and includes two sub-cohorts: Cohort IIa is defined as non- concussed injured athletes; Cohort IIb concussed athletes per reference standard.
Type d'étude
Observationnel
Inscription (Réel)
353
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
Wyoming
-
Laramie, Wyoming, États-Unis, 82070
- University of Wyoming
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
18 ans à 28 ans (Adulte)
Accepte les volontaires sains
Oui
Sexes éligibles pour l'étude
Tout
Méthode d'échantillonnage
Échantillon non probabiliste
Population étudiée
Athletes participating in Division 1 Athletics at the University of Wyoming
La description
Inclusion Criteria:
- Male or female young athletes between ages 18-28 yrs
- Enrolled at the University of Wyoming and currently participating in Division 1 Athletics
- Completed the following baseline testing: SWAY balance, King-Devick, C3-Logix
- Willing and able to participate in all study evaluations and allow access to medical testing and records
- Signed informed consent, or have a legally authorized representative willing to provide informed consent on behalf of the subject if the subject is a minor
Exclusion Criteria:
- Prior concussion diagnosed by a physician in the last 2 weeks assessed via interview with athlete (not including a recent concussion within the last 3 days)
- Any serious medical, social or psychological condition that in the opinion of the investigator would impair ability to provide informed consent or otherwise disqualify a patient from participation
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
Cohort Ia
Athletes in this cohort serve as control subjects participating in Division 1 Athletics at the University of Wyoming.
They will be enrolled once they meet eligibility.
Upon enrollment, all athletes will have an initial BrainPulse recording.
Once a subject from this cohort sustains an injury, they crossover to Cohort II.
Also, a matched control for every concussed subject will be selected from Cohort Ia.
|
JanMedical's BrainPulse measures the brain motion caused by pulsatile blood flow from the cardiac cycle referred to as the BrainPulse signal.
The BrainPulse measures skull acceleration in response to tge brain motion using an array of sensors placed on the head.
|
|
Cohort Ib
Athletes in this cohort are subjects currently subscribed to the Head Health Network.
They will have a BrainPulse recording completed every week through the entire season.
Similarly, if subjects in this cohort sustain an injury, they will crossover to Cohort II.
|
JanMedical's BrainPulse measures the brain motion caused by pulsatile blood flow from the cardiac cycle referred to as the BrainPulse signal.
The BrainPulse measures skull acceleration in response to tge brain motion using an array of sensors placed on the head.
|
|
Cohort IIa
Athletes from Cohort I will be assigned to cohort IIa once they sustain an injury other than concussion.
They will have been pulled out of the game by the athletic trainer and removed from play until at least the end of the game.
Once the subjects have been assigned to Cohort IIa, they will have a BrainPulse recording and a symptom evaluation within 3 days of their injury.
After two weeks of recovery, subjects in this cohort will return to Cohort 1 and resume their participation in the study in their respective sub-cohort.
|
JanMedical's BrainPulse measures the brain motion caused by pulsatile blood flow from the cardiac cycle referred to as the BrainPulse signal.
The BrainPulse measures skull acceleration in response to tge brain motion using an array of sensors placed on the head.
|
|
Cohort IIb
Athletes in this cohort are injured subjects who sustain a non-penetrating head injury and are confirmed to have had a concussion according to the protocol reference standard and by their physician.
All subjects enrolled in this cohort are required to have a BrainPulse recording within 3 days of their injury.
Each BrainPulse recording will be accompanied by a symptoms evaluation and medical data collection documented in the case report forms.
Subjects will complete 3 weeks of follow-up visits post injury.
|
JanMedical's BrainPulse measures the brain motion caused by pulsatile blood flow from the cardiac cycle referred to as the BrainPulse signal.
The BrainPulse measures skull acceleration in response to tge brain motion using an array of sensors placed on the head.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Comparison of BrainPulse recordings of concussed subjects with BrainPulse recordings from their matched Controls
Délai: Through study completion, expected to be 8 months
|
Collect BrainPulse data from at least 15 concussed athletes and matched controls to develop and improve algorithms that can aid in the diagnosis of concussion. The specific signal patterns observed from confirmed concussed subjects' BrainPulse recordings will be evaluated against the BrainPulse recordings from the matched control subjects. |
Through study completion, expected to be 8 months
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Correlate helmet sensor's force of impact measurements with BrainPulse data
Délai: Through study completion, expected to be 8 months
|
Compare the magnitude of force measured by helmet sensors from subconcussive hits with consecutive BrainPulse recordings.
As such, BrainPulse data on these athletes will be compared with helmet sensor data, baseline cognitive testing, and the initial BrainPulse recording.
|
Through study completion, expected to be 8 months
|
|
Compare BrainPulse Data between Injured Athletes, Non-Injured athletes, and Concussed Athletes
Délai: Through study completion, expected 8 months
|
Compare BrainPulse signals in subjects sustaining a non-concussive injury to subjects that have a confirmed diagnosis of concussion.
Also compare BrainPulse signals from injured subjects in Cohort IIa with non-injured subjects in Cohort Ia.
|
Through study completion, expected 8 months
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
1 novembre 2016
Achèvement primaire (Réel)
1 mai 2017
Achèvement de l'étude (Réel)
1 août 2017
Dates d'inscription aux études
Première soumission
12 décembre 2016
Première soumission répondant aux critères de contrôle qualité
12 décembre 2016
Première publication (Estimation)
14 décembre 2016
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
20 septembre 2018
Dernière mise à jour soumise répondant aux critères de contrôle qualité
18 septembre 2018
Dernière vérification
1 septembre 2018
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- JMC-1602
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
NON
Description du régime IPD
All study outcome measures will be made available within 6 months of study completion
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .